About tlcr

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

Editorial Commentary

Targeting MET amplification in non–small cell lung cancer: encouraging results with vebreltinib from the phase II KUNPENG study
Edyta Maria Urbanska, Morten Grauslund, Jens Benn Sørensen, Eric Santoni-Rugiu
Translational Lung Cancer Research  
2026;
15
(6)
:160
.
Is TROP2 ADC ready for EGFR-TKI-resistant NSCLC?
Jiefei Han, Keigo Kobayashi, Rogelio N. Velasco, Aaron C. Tan
Translational Lung Cancer Research  
2026;
15
(6)
:161
.

Original Article

A retrospective cohort study of operated older patients undergoing lung resection after PFT-based versus CPET-based preoperative stratification
Hua Sun, Minghui Yang, Minhua Ye, Bei Ye, Hao Liu, Zhongxiao Chen, William C. Cho, Pasan Witharana, Dehua Ma, Min Kong, Chengchu Zhu, Chenyang Dai, Jianfei Shen
Translational Lung Cancer Research  
2026;
15
(6)
:162
.
Neoadjuvant therapy followed by tracheal/carinal resection and reconstruction: perioperative and long-term outcomes
Jiawei Chen, Hongsheng Deng, Jiawei Li, Jiang Long, Yunjuan Liang, Zhongqiao Mo, Chao Yang, Jianxing He, Shuben Li
Translational Lung Cancer Research  
2026;
15
(6)
:163
.
Neoadjuvant chemoimmunotherapy in resected stage III non-small-cell lung cancer: real-world data from a nationwide registry
Xavier Vaillo, Carlos Gálvez, Sergio Bolufer, Francisco Lirio, Sergi Call, Unai Jiménez, Jon Zabaleta, M. Teresa Gómez, Laura Sánchez, L. Jorge Cerezal
Translational Lung Cancer Research  
2026;
15
(6)
:164
.
Tumor-distant pulmonary immune landscapes are associated with postoperative outcomes in non-small cell lung cancer
Masaya Aoki, Go Kamimura, Shoichiro Morizono, Yuto Nonaka, Takuya Tokunaga, Aya Harada-Takeda, Koki Maeda, Toshiyuki Nagata, Yuka Ishihara, Gen Murakami, Kazuhiro Ueda
Translational Lung Cancer Research  
2026;
15
(6)
:165
.
Computed tomography-based deep learning prediction of radiation-induced functional decline after lung cancer radiotherapy
Jung Chun Kim, Seonhwa Kim, Jun Hyeong Park, Jaesung Heo
Translational Lung Cancer Research  
2026;
15
(6)
:166
.
LPIN2 contributes to tyrosine kinase inhibitor resistance via activation of PI3K pathway
Guanyu Zhou, Kejia Zhao, Hao Luo, Yin Ku, Haoning Peng, Shasha Li, Wenjing Zhou, Nanzhi Luo, Lunxu Liu, Yaohui Chen
Translational Lung Cancer Research  
2026;
15
(6)
:167
.
End-of-life management and causes of death in ALK-positive non-small cell lung cancer in France: a multicentric analysis
Gaspard Naulleau, Gary Birsen, Pascal Wang, Vincent Fallet, Gaelle Rousseau Bussac, Boris Duchemann, Elizabeth Fabre, Gérard Zalcman, Etienne Giroux Leprieur, Karen Leroy, Hélène Blons, Audrey Lupo, Marie Wislez
Translational Lung Cancer Research  
2026;
15
(6)
:168
.
Development and validation of a dual-attention deep learning prediction model for noninvasive differentiation of pulmonary invasive mucinous adenocarcinoma from inflammatory pulmonary nodules
Jiading Xie, Shiqing Wang, Junjie Cheng, Qizheng Wei, Haitang Yang, Feng Yao
Translational Lung Cancer Research  
2026;
15
(6)
:169
.
Osalmid inhibits lung adenocarcinoma progression and enhances EGFR-TKI responses: a preclinical and translational study
Leilei Wu, Zhijian Xu, Wenmei Jiang, Shangshang Ma, Diego Gonzalez-Rivas, Weiliang Zhu, Dong Xie
Translational Lung Cancer Research  
2026;
15
(6)
:170
.
Prediction of peak oxygen uptake using interpretable machine learning on routinely available preoperative assessments before lung resection
Se-Hun Kim, Sa-Eun Park, Cho Hui Hong, Tae-Sung Park, Myung-Jun Shin, Ki-Hun Kim, Sang-Hun Kim
Translational Lung Cancer Research  
2026;
15
(6)
:171
.
A recurrence risk prediction model and recurrence patterns in pulmonary lymphoepithelial carcinoma based on clinical and dynamic hematologic parameters
Haiwen Chen, Gengda Huang, Hong He, Qinqin Ren, Yuting Fan, Silu Chen, Li Luo, Jian Xie, Jiacheng Zhou, Jingpei Li, Chengzhi Zhou, Jiexia Zhang
Translational Lung Cancer Research  
2026;
15
(6)
:172
.
Efficacy of ipilimumab plus nivolumab with or without chemotherapy according to baseline tumor size: a multicenter retrospective study
Hisashi Tanaka, Tomonori Makiguchi, Takehiro Tozuka, Yosuke Kawashima, Tomohiro Oba, Ryosuke Tsugitomi, Junji Koyama, Yuichi Tambo, Shinsuke Ogusu, Masafumi Saiki, Hiroshi Gyotoku, Tsukasa Hasegawa, Eisaku Miyauchi, Tomoaki Sonoda, Ryota Saito, Katsumi Nakatomi, Toshio Sakatani, Keita Kudo, Yuko Tsuchiya-Kawano, Makoto Nishio
Translational Lung Cancer Research  
2026;
15
(6)
:173
.
The impact of local tumor immune responses on prognosis in resected lung adenocarcinoma
Yoshinobu Ichiki, Anna Takimoto, Yuri Sugawara, Ryo Taguchi, Tetsuya Umesaki, Hiroyuki Nitanda, Tomoyuki Hishida, Tomonori Kawasaki, Taku Homma, Ou Yamaguchi, Atsuto Mouri, Hisao Imai, Kyoichi Kaira, Hiroshi Kagamu
Translational Lung Cancer Research  
2026;
15
(6)
:174
.
Ultrasound assessment of pleural invasion via visceral pleura interruption and arch distance-to-tumour diameter ratio in a rabbit model of subpleural lung cancer
Shiyu Zhang, Mengting Shu, Yue Lin, Yuxin Zhang, Guosheng Liang, Wuxin Chen, Dongjun Wei, Liantu He, Qing Tang, Jiaxin Tang, Hongwei Yang
Translational Lung Cancer Research  
2026;
15
(6)
:175
.
Assessment of tumor mutation burden based on whole-exome sequencing of extracellular vesicle-derived DNA from bronchoalveolar lavage fluid in advanced non-small cell lung cancer treated with pembrolizumab: a prospective, multicenter, observational study
Heejoung Kim, Jaeyoung Hur, Wan Seop Kim, In Ae Kim, Dongil Park, In-Jae Oh, Seung-Jae Noh, Hyoeun Bang, Kye Young Lee
Translational Lung Cancer Research  
2026;
15
(6)
:176
.
Lobectomy, segmentectomy, and wedge resection for elderly patients with solid-predominant stage I NSCLC: survival, pulmonary function, and postoperative outcomes
Yaoxi Zhang, Yudong Tang, Kunhao Wu, Sangrou Xu, Qixia Yuan, Ruili Zhong, Fucheng Zheng, Quan Zheng, Yuchen Huang, Jinhan Wang, Ai Lin, Mengyuan Lyu, Jiandong Mei, Jian Zhou
Translational Lung Cancer Research  
2026;
15
(6)
:177
.
Development and validation of a PET/CT radiomics and dual-task learning model for the prediction of pathological subtypes and EGFR mutation in non-small cell lung cancer
Fan Jiang, Nan-Feng Zhang, Yi Gao, Xin Chen, En-Tao Liu, Tian Mou
Translational Lung Cancer Research  
2026;
15
(6)
:178
.
Prognostic analysis and beneficiary population exploration of subsequent treatment regimens after third-generation EGFR-TKIs failure in EGFR-mutated advanced non-small cell lung cancer: a retrospective cohort study
Zipeng Wu, Tianyi Liu, Ruofan Yu, Jingwen Li, Shuyi Hu, Caolu Liu, Xinyu Du, Xinhong Shi, Yingying Dai, Lin Lu, Yuxin Ma, Yingying Jiang, Yue Shi, Guoren Zhou, Cheng Chen, Jiamin Shi, Ning Ding, Xiaohua Wang
Translational Lung Cancer Research  
2026;
15
(6)
:179
.
Impact of chronic obstructive pulmonary disease on the prognosis of patients with extensive-stage small-cell lung cancer treated with chemoimmunotherapy
Yuxin Jiang, Yu Li, Yanjun Du, Bei Jiang, Qianqian Zhang, Qinpei Cheng, Wanjun Lu, Xueying Zuo, Qiuxia Wu, Shuo Liang, Yong Song, Wenjie Yan, Tangfeng Lv, Ping Zhan
Translational Lung Cancer Research  
2026;
15
(6)
:180
.

Study Protocol

Consolidation thoracic radiotherapy following quadruple induction with benmelstobart, anlotinib, and chemotherapy for extensive-stage small cell lung cancer: rationale and protocol of a phase II study
Yuntao Zhou, Hui Zhu, Siyi Yang, Jialei Liu, Miao Yu, Jifeng Sun, Chengwen Yang, Yong Cui, Ningbo Liu
Translational Lung Cancer Research  
2026;
15
(6)
:181
.

Review Article

Inconsistent definitions of radical resection in perioperative trials of non-small cell lung cancer: a scoping review
Julia Niedzielska, Natalia Szczepańska, Aleksandra Ciarka, Rafał Pęksa, Łukasz Szylberg, Jędrzej Borowczak, Tomasz Marjański
Translational Lung Cancer Research  
2026;
15
(6)
:182
.
Current advances in extended resections for non-small cell lung cancer—a narrative review
Katharina Sinn, Merjem Begic, Mir Alireza Hoda, Clemens Aigner
Translational Lung Cancer Research  
2026;
15
(6)
:183
.
A narrative review on CT-based evaluation and prediction of lung nodule growth: current status and future directions
Qinling Jiang, Xin’ang Jiang, Xufan Wu, Yuyan Lei, Ningyang Jia
Translational Lung Cancer Research  
2026;
15
(6)
:184
.
Over- and underscreening for lung cancer
Hang Cao, Yang Zhang, Fangqiu Fu, Haiquan Chen
Translational Lung Cancer Research  
2026;
15
(6)
:185
.

Case Report

Complete response in disseminated EGFR-mutated lung adenocarcinoma through chemosensitivity-guided chemotherapy, osimertinib, and stereotactic ablative body radiotherapy: a case report
Emilija Lozo Vukovac, Iva Perić, Anja Batel, Vide Popović, Ivana Marinović-Terzić
Translational Lung Cancer Research  
2026;
15
(6)
:186
.
Atypical type D extended sleeve resection after neoadjuvant chemoimmunotherapy in a 69-year-old man with locally advanced lung cancer and a tracheobronchial branching anomaly: a case report
Chiaki Kanno, Takuya Nagashima, Yui Kaburaki, Naoko Shigeta, Ikki Takada, Ryotaro Matsuyama, Shunsuke Shigefuku, Shu Yuguchi, Kota Washimi, Tetsuya Isaka, Yoichiro Okubo, Tomoyuki Yokose, Hiroyuki Ito
Translational Lung Cancer Research  
2026;
15
(6)
:187
.
Remarkable response to personalized combination immunotherapy of nivolumab plus ipilimumab in an 84-year-old patient with locally advanced squamous cell carcinoma: a case report
Ruifeng Li, Jiawei Chen, Zijian Li, Dixuan Zhang, Shuben Li
Translational Lung Cancer Research  
2026;
15
(6)
:188
.
Cisplatin re-challenge following recovery from carboplatin-induced, biopsy-proven acute tubular necrosis in a 57-year-old patient with squamous-transformed non-small cell lung cancer: a case report
Toru Morikawa, Yosuke Dotsu, Kenta Torigoe, Mineaki Kitamura, Mayako Mori, Seiya Kaneko, Noritaka Honda, Kazumasa Akagi, Hiromi Tomono, Midori Matsuo, Hirokazu Taniguchi, Shinnosuke Takemoto, Tomoya Nishino, Hiroshi Mukae
Translational Lung Cancer Research  
2026;
15
(6)
:189
.

Letter to the Editor

Refining the clinical interpretation of GLUT1 in non-small cell lung cancer
Minmin Hu, Chuanfeng Wu
Translational Lung Cancer Research  
2026;
15
(6)
:190
.
Review Article 
Non-small cell lung cancer: current treatment and future advances
Cecilia Zappa, Shaker A. Mousa
Published online: 30 June 2016
Review Articles 
Irreversible EGFR-TKIs: dreaming perfection
Lorenza Landi, Federico Cappuzzo
Published online: 14 January 2013
Review Article 
Pulmonary ground-glass opacity: computed tomography features, histopathology and molecular pathology
Jian-Wei Gao, Stefania Rizzo, Li-Hong Ma, Xiang-Yu Qiu, Arne Warth, Nobuhiko Seki, Mizue Hasegawa, Jia-Wei Zou, Qian Li, Marco Femia, Tang-Feng Lv, Yong Song, written on behalf of the AME Lung Cancer Collaborative Group
Published online: 28 February 2017
Review Article 
Recurrence after surgery in patients with NSCLC
Hidetaka Uramoto, Fumihiro Tanaka
Published online: 28 August 2014
Review Article 
Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and treatment
Tianli Zhang, Bing Wan, Yuan Zhao, Chuling Li, Hongbing Liu, Tangfeng Lv, Ping Zhan, Yong Song
Published online: 30 June 2019
Review Article 
Ground-glass nodules of the lung in never-smokers and smokers: clinical and genetic insights
Yoshihisa Kobayashi, Chiara Ambrogio, Tetsuya Mitsudomi
Published online: 28 August 2018
Review Article 
Targeted therapy for non-small cell lung cancer: current standards and the promise of the future
Bryan A. Chan, Brett G.M. Hughes
Published online: 24 February 2015
Review Article 
Lung cancer prediction using machine learning and advanced imaging techniques
Timor Kadir, Fergus Gleeson
Published online: 14 June 2018
Review Article 
The past, present and future of immunotherapy against tumor
Tao Jiang, Caicun Zhou
Published online: 24 June 2015
Review Article 
The epidemiology of lung cancer
Patricia M. de Groot, Carol C. Wu, Brett W. Carter, Reginald F. Munden
Published online: 14 June 2018
Review Article 
Lung cancer screening: nodule identification and characterization
Ioannis Vlahos, Konstantinos Stefanidis, Sarah Sheard, Arjun Nair, Charles Sayer, Joanne Moser
Published online: 14 June 2018
Review Article on Update on Pathology and Predictive Biomarkers of Lung Cancer 
Biology of invasive mucinous adenocarcinoma of the lung
Yoon Jin Cha, Hyo Sup Shim
Published online: 11 October 2017
Review Article 
Molecular testing strategies in non-small cell lung cancer: optimizing the diagnostic journey
Jeffrey P. Gregg, Tianhong Li, Ken Y. Yoneda
Published online: 30 June 2019
Review Articles 
KRAS mutant NSCLC, a new opportunity for the synthetic lethality therapeutic approach
Javier de Castro Carpeño, Cristóbal Belda-Iniesta
Published online: 03 April 2013
Consensus 
Tubeless video-assisted thoracic surgery for pulmonary ground-glass nodules: expert consensus and protocol (Guangzhou)
Jianxing He, Hengrui Liang, Wei Wang, Andrey Akopov, Alberto Aiolfi, Keng-Leong Ang, Luca Bertolaccini, Kaican Cai, Qingdong Cao, Baojun Chen, Chang Chen, Chun Chen, Donglai Chen, Fengxia Chen, Jun Chen, Lei Chen, Mingwu Chen, Yongbing Chen, Zhuxing Chen, Chao Cheng, Dong Cui, Fei Cui, Tianyang Dai, Qinglong Dong, Paolo A. Ferrari, Raja M. Flores, Junke Fu, Soichiro Funaki, Marios E. Froudarakis, Xiangfeng Gan, Mingfei Geng, Jialong Guo, Qiang Guo, Yongtao Han, Jintao He, Kaiming He, Kyoji Hirai, Jian Hu, Shuqiao Hu, Jian Huang, Jun Huang, Wenfa Jiang, Kyung Soo Kim, Gabor Kiss, Fanyi Kong, Lan Lan, Xuefeng Leng, Bin Li, Gaofeng Li, Hecheng Li, Hefei Li, Heng Li, Jiwei Li, Xiaoqiang Li, Shuben Li, Yinfen Li, Zhuoyi Li, Yi Liang, Lixia Liang, Wenhua Liang, Yongde Liao, Wanli Lin, Xu Lin, Hongxu Liu, Hui Liu, Jixian Liu, Jun Liu, Xiang Liu, Zihao Liu, Xingzhao Lu, Qingquan Luo, Naiquan Mao, Qi Pan, Dazhi Pang, Jun Peng, Jun Peng, Eugenio Pompeo, Rulin Qian, Kun Qiao, Bassam Redwan, Zi Sang, Wenlong Shao, Jianfei Shen, Weiyu Shen, Sook-Whan Sung, Wenfang Tang, Tianhu Wang, Guangsuo Wang, Haitao Wang, Huien Wang, Jiyong Wang, Wen Wang, Yongyong Wang, Zhenyuan Wang, Li Wei, Wei Wei, Hao Wu, Jie Wu, Zhaohua Xia, Chenyang Xu, Enwu Xu, Hai Xu, Ning Xu, Quan Xu, Rongyu Xu, Shun Xu, Chaokun Yang, Hanyu Yang, Shengli Yang, Jun Yi, Guangjian Zhang, Hao Zhang, Jia Zhang, Man Zhang, Xiao Zhang, Yajie Zhang, Zhe Zhang, Zhifeng Zhang, Honglin Zhao, Jian Zhao, Xiaodong Zhao, Jianping Zhou, Yanran Zhou, Chengchu Zhu, Shaojin Zhu, Xinhai Zhu, Jian Cui, Yubo Yan, Ke-Neng Chen
Published online: 28 August 2021
Review Article 
Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer
Takashi Kohno, Takashi Nakaoku, Koji Tsuta, Katsuya Tsuchihara, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto
Published online: 19 April 2015
Review Article 
Global trends of lung cancer mortality and smoking prevalence
Farhad Islami, Lindsey A. Torre, Ahmedin Jemal
Published online: 20 August 2015
Review Articles 
Angiogenesis in cancer: anti-VEGF escape mechanisms
Gerald W. Prager, Marina Poettler, Matthias Unseld, Christoph C. Zielinski
Published online: 18 February 2012

Original Article

Prognostic value of Twist in lung cancer: systematic review and meta-analysis
Junli Zeng, Ping Zhan, Guannan Wu, Wen Yang, Wenjun Liang, Tangfeng Lv, Yong Song
BRAF mutations in non-small cell lung cancer
Peter P. Luk, Bing Yu, Chiu Chin Ng, Belinda Mercorella, Christina Selinger, Trina Lum, Steven Kao, Sandra A. O’Toole, Wendy A. Cooper
The suitability of small biopsy and cytology specimens for EGFR and other mutation testing in non-small cell lung cancer
Shu Wang, Bing Yu, Chiu Chin Ng, Belinda Mercorella, Christina I. Selinger, Sandra A. O’Toole, Wendy A. Cooper
Itraconazole can inhibit malignant pleural effusion by suppressing lymphangiogenesis in mice
Yunfen Wang, Yanwen Yao, Hongbin Liu, Xingqun Ma, Tangfeng Lv, Dongmei Yuan, Xinwu Xiao, Jie Yin, Yong Song
Ratio of maximum standardized uptake value to primary tumor size is a prognostic factor in patients with advanced non-small cell lung cancer
Fangfang Chen, Yanwen Yao, Chunyan Ma, Xingqun Ma, Zhaofeng Wang, Tangfeng Lv, Xinwu Xiao, Jie Yin, Yong Song
Advanced proton beam dosimetry part II: Monte Carlo vs. pencil beam-based planning for lung cancer
Dominic Maes, Jatinder Saini, Jing Zeng, Ramesh Rengan, Tony Wong, Stephen R. Bowen
The cytokinesis-blocked micronucleus assay as a novel biomarker for selection of lung cancer screening participants
Randa A. El-Zein, Carol J. Etzel, Reginald F. Munden
The use of TCP based EUD to rank and compare lung radiotherapy plans: in-silico study to evaluate the correlation between TCP with physical quality indices
Abdulhamid Chaikh, Jacques Balosso

Review Article

Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer
Takashi Kohno, Takashi Nakaoku, Koji Tsuta, Katsuya Tsuchihara, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto
Overview of clinicopathologic features of ALK-rearranged lung adenocarcinoma and current diagnostic testing for ALK rearrangement
Hyojin Kim, Jin-Haeng Chung
Neoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer
Haoran Zhai, Wenzhao Zhong, Xuening Yang, Yi-Long Wu
Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations—a review
Erin L. Stewart, Samuel Zhixing Tan, Geoffrey Liu, Ming-Sound Tsao
Clinical trials for lung cancer in China
Fei-Yu Niu, Wen-Zhao Zhong, Qing Zhou, Yi-Long Wu
Recurrence after surgery in patients with NSCLC
Hidetaka Uramoto, Fumihiro Tanaka
Prognostic markers in lung cancer: is it ready for prime time?
Chang-Qi Zhu, Ming-Sound Tsao
Potential biomarkers for lung cancer screening
Gabriella Sozzi, Mattia Boeri
Particle therapy in non-small cell lung cancer
Zhongxing Liao, Charles B. Simone II
Computer Aided Nodule Analysis and Risk Yield (CANARY) characterization of adenocarcinoma: radiologic biopsy, risk stratification and future directions
Ryan Clay, Srinivasan Rajagopalan, Ronald Karwoski, Fabien Maldonado, Tobias Peikert, Brian Bartholmai
Immunotherapy and radiation therapy for operable early stage and locally advanced non-small cell lung cancer
Neil K. Taunk, Andreas Rimner, Melissa Culligan, Joseph S. Friedberg, Julie Brahmer, Jamie Chaft
Combining immunotherapy and radiation therapy for small cell lung cancer and thymic tumors
Suchit H. Patel, Andreas Rimner, Roger B. Cohen
Intraoperative near-infrared imaging of mesothelioma
Gregory Thomas Kennedy, Andrew Newton, Jarrod Predina, Sunil Singhal
BAP1, a tumor suppressor gene driving malignant mesothelioma
Mitchell Cheung, Joseph R. Testa
Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation
Jonathan E. Schoenhals, Steven N. Seyedin, Clark Anderson, Eric D. Brooks, Yun R. Li, Ahmed I. Younes, Sharareh Niknam, Ailin Li, Hampartsoum B. Barsoumian, Maria Angelica Cortez, James W. Welsh
Diagnostic and prognostic biomarkers for malignant mesothelioma: an update
Zhongjian Chen, Giovanni Gaudino, Harvey I. Pass, Michele Carbone, Haining Yang
Immunotherapy for malignant pleural mesothelioma: current status and future directions
Jordan Dozier, Hua Zheng, Prasad S. Adusumilli
Biology and clinical significance of circulating tumor cell subpopulations in lung cancer
Linda O’Flaherty, Harriet Wikman, Klaus Pantel
Routine clinical use of circulating tumor cells for diagnosis of mutations and chromosomal rearrangements in non-small cell lung cancer—ready for prime-time?
Emma Pailler, Vincent Faugeroux, Marianne Oulhen, Cyril Catelain, Françoise Farace
Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer
Sumitra Mohan, Francesca Chemi, Ged Brady
Biophysical technologies for understanding circulating tumor cell biology and metastasis
Derrick W. Su, Jorge Nieva
Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer
Marianna Gallo, Antonella De Luca, Monica Rosaria Maiello, Amelia D’Alessio, Claudia Esposito, Nicoletta Chicchinelli, Laura Forgione, Maria Carmela Piccirillo, Gaetano Rocco, Alessandro Morabito, Gerardo Botti, Nicola Normanno
Integrating immunotherapy into chemoradiation regimens for medically inoperable locally advanced non-small cell lung cancer
Salma K. Jabbour, Abigail T. Berman, Charles B. Simone II

Systematic Review and Meta-analysis

Association of the metformin with the risk of lung cancer: a meta-analysis
Li Wang, Yong Song, Guan-Nan Wu, Dong-Mei Yuan

Editorials

Dulanermin in cancer therapy: Still much to do
Cristina Quintavalle, Gerolama Condorelli

Review Articles

EGFR molecular testing in African-American non-small cell lung cancer patients - a review of discrepant data
Bradley T. Clifford, Pingfu Fu, Nathan A. Pennell, Balazs Halmos, Rom S. Leidner
Copy number gains of FGFR1 and 3q chromosome in squamous cell carcinoma of the lung
Pedro Mendez, Jose Luis Ramirez
Role of HGF/MET axis in resistance of lung cancer to contemporary management
Kanwal Pratap Singh Raghav, Ana Maria Gonzalez-Angulo, George R. Blumenschein Jr
Circulating soluble intercellular adhesion Molecule-1 in lung cancer: a systematic review
Xiaoling Gu, Chunyan Ma, Dongmei Yuan, Yong Song

Onartuzumab plus erlotinib

Targeting MET in NSCLC: looking for a needle in a haystack
Lorenza Landi, Federico Cappuzzo

Review Article on Update on Pathology and Predictive Biomarkers of Lung Cancer

Biology of invasive mucinous adenocarcinoma of the lung
Yoon Jin Cha, Hyo Sup Shim
Immunohistochemistry for predictive biomarkers in non-small cell lung cancer
Mari Mino- Kenudson